We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.05B
AUM Growth
+$503M
Cap. Flow
+$454M
Cap. Flow %
11.2%
Top 10 Hldgs %
55.84%
Holding
654
New
120
Increased
131
Reduced
191
Closed
155

Sector Composition

Rank Sector Weight
1 Energy 20.91%
2 Technology 19.62%
3 Healthcare 14.36%
4 Industrials 11.13%
5 Consumer Staples 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSX icon
326
Boston Scientific
BSX
$71.4B
$572K 0.01%
6,827
-273
-4% -$21.5K
RIG icon
327
PUT
Transocean
RIG
$5.71B
$567K 0.01%
403,400
ACRV icon
328
Acrivon Therapeutics
ACRV
$72.3M
$555K 0.01%
79,249
-26,000
-25% -$205K
F icon
329
PUT
Ford
F
$55B
$547K 0.01%
570,900
EWTX icon
330
Edgewise Therapeutics
EWTX
$4.78B
$534K 0.01%
20,000
-65,008
-76% -$1.29M
SDGR icon
331
Schrodinger
SDGR
$1.33B
$525K 0.01%
28,316
+8,305
+42% +$171K
IWM icon
332
CALL
iShares Russell 2000 ETF
IWM
$82.1B
$522K 0.01%
+160,000
New +$34.2M
PTON icon
333
PUT
Peloton Interactive
PTON
$2.38B
$518K 0.01%
500,000
EPR icon
334
EPR Properties
EPR
$4.7B
$510K 0.01%
10,400
-1,800
-15% -$82.2K
ALLK
335
DELISTED
Allakos
ALLK
$508K 0.01%
777,702
+61,137
+9% +$44.3K
MRUS
336
DELISTED
Merus
MRUS
$496K 0.01%
9,922
+922
+10% +$48.1K
RCUS icon
337
Arcus Biosciences
RCUS
$3.61B
$487K 0.01%
31,862
-33,325
-51% -$525K
MGM icon
338
PUT
MGM Resorts International
MGM
$11.2B
$481K 0.01%
125,000
-125,000
-50% -$4.94M
EW icon
339
Edwards Lifesciences
EW
$51.5B
$462K 0.01%
+7,000
New +$509K
GLW icon
340
Corning
GLW
$135B
$452K 0.01%
+10,000
New +$421K
VTYX
341
DELISTED
Ventyx Biosciences
VTYX
$436K 0.01%
+200,000
New +$460K
HLF icon
342
PUT
Herbalife
HLF
$1.21B
$424K 0.01%
82,400
CYPH
343
Cypherpunk Technologies Inc
CYPH
$71.7M
$424K 0.01%
165,108
+15,336
+10% +$37.6K
ARDX icon
344
Ardelyx
ARDX
$1.2B
$418K 0.01%
60,736
-23,857
-28% -$141K
CGON icon
345
CG Oncology
CGON
$6.6B
$416K 0.01%
11,024
+1,024
+10% +$35.9K
VSAT icon
346
PUT
Viasat
VSAT
$11.3B
$407K 0.01%
73,300
CRGX
347
DELISTED
CARGO Therapeutics
CRGX
$407K 0.01%
22,048
+2,048
+10% +$36.6K
TERN
348
DELISTED
Terns Pharmaceuticals
TERN
$400K 0.01%
+48,000
New +$395K
BDTX icon
349
Black Diamond Therapeutics
BDTX
$110M
$395K 0.01%
90,706
-213,000
-70% -$1.16M
SABR icon
350
PUT
Sabre
SABR
$886M
$393K 0.01%
688,600

Similar funds

UBS O'Connor's Q3 2024 Portfolio in Review

As of Q3 2024, UBS O'Connor held 654 positions worth $4.05B, up 14% from $3.55B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor deployed $454M of net new capital in Q3 2024, opening 120 new positions and adding to 131 existing holdings. Its largest new stake was Kellanova: 3,778,689 shares worth $305M.

By sector, the portfolio is most concentrated in Energy at 21% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was US Steel, an estimated $20.2M trimmed.

  • UBS O'Connor's largest Q3 2024 buy was Kellanova: 3,778,689 shares worth $305M.
  • UBS O'Connor added most to Stericycle Inc in Q3 2024, an estimated $141M increase.
  • UBS O'Connor's biggest Q3 2024 reduction was US Steel, cutting an estimated $20.2M.
  • UBS O'Connor fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $149M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.05B portfolio in Q3 2024.
  • UBS O'Connor opened 120 new positions and closed 155 in Q3 2024.
  • UBS O'Connor's portfolio value rose 14% quarter-over-quarter to $4.05B.

Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.